Correction to: COVID-19 Outcomes and Vaccination in People with Relapsing Multiple Sclerosis Treated with Ofatumumab (Neurology and Therapy, (2022), 10.1007/s40120-022-00341-z)

Anne H. Cross, Silvia Delgado, Mario Habek, Maria Davydovskaya, Brian J. Ward, Bruce A.C. Cree, Natalia Totolyan, Ratnakar Pingili, Linda Mancione, Xixi Hu, Roseanne Sullivan, Wendy Su, Ronald Zielman, Ayan Das Gupta, Xavier Montalban, Kevin Winthrop

Research output: Contribution to journalComment/debatepeer-review

Abstract

In the published article a few errors have been identified, these have subsequently been rectified. Alterations were also made to sentences and reference numbering to improve the clarity of sentences and better reflect the published literature. These changes did not impact upon the conclusions of the article.

Original languageEnglish (US)
JournalNeurology and Therapy
DOIs
StateAccepted/In press - 2022

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Fingerprint

Dive into the research topics of 'Correction to: COVID-19 Outcomes and Vaccination in People with Relapsing Multiple Sclerosis Treated with Ofatumumab (Neurology and Therapy, (2022), 10.1007/s40120-022-00341-z)'. Together they form a unique fingerprint.

Cite this